Posts
-
First Drug to Reduce Risk of Mortality and Hospitalization in Heart Failure
Dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, reduced the risk of cardiovascular-related morality and hospitalization in patients with heart failure, regardless of ejection fraction, according to a series of clinical trial reports.
-
Advancing Lung Health Through Discovery-Based Research
Chronic lung disease is still the fourth leading cause of death in the U.S., making chronic lung disease both a research and clinical priority for many academic medical centers across the U.S. — including the Feinberg School of Medicine.
-
Gene Loss Enhances Metastasis and Cancer Progression
Investigators discovered that the loss of the gene SLIT2 in circulating tumor cells regulates metastasis of prostate cancer tumors, according to a Northwestern Medicine study.